Globe Life (NYSE:GL) CEO Sells $2,657,941.80 in Stock

Globe Life Inc. (NYSE:GL) CEO James Matthew Darden sold 18,318 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total value of $2,657,941.80. Following the completion of the sale, the chief executive officer owned 51,093 shares in the company, valued at approximately $7,413,594.30. This represents a 26.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

James Matthew Darden also recently made the following trade(s):

• On Friday, February 27th, James Matthew Darden sold 9,527 shares of Globe Life stock. The stock was sold at an average price of $144.34, for a total value of $1,375,127.18.

Globe Life Stock Down 0.7%

Globe Life stock opened at $142.41 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07. The firm has a market capitalization of $11.20 billion, a price-to-earnings ratio of 10.11 and a beta of 0.46. Globe Life Inc. has a fifty-two week low of $109.38 and a fifty-two week high of $152.71. The stock’s fifty day moving average is $142.04 and its two-hundred day moving average is $138.96.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Analysts predict that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, April 2nd. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s dividend payout ratio is presently 7.67%.

Institutional Investors Weigh In On Globe Life

A number of institutional investors have recently added to or reduced their stakes in GL. Hsbc Holdings PLC raised its holdings in shares of Globe Life by 19.0% in the 4th quarter. Hsbc Holdings PLC now owns 129,997 shares of the company’s stock worth $18,225,000 after purchasing an additional 20,743 shares during the period. MidFirst Bank purchased a new position in Globe Life in the fourth quarter valued at approximately $529,000. Compound Planning Inc. raised its holdings in Globe Life by 4.3% in the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after buying an additional 82 shares during the period. Invesco Ltd. lifted its position in Globe Life by 2.7% during the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after buying an additional 102,445 shares in the last quarter. Finally, Strive Financial Group LLC acquired a new position in Globe Life during the fourth quarter valued at approximately $1,974,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on GL shares. Truist Financial raised their price target on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. Evercore set a $157.00 price objective on Globe Life in a research report on Wednesday, February 18th. Morgan Stanley reiterated an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a research note on Monday, December 15th. Wells Fargo & Company increased their target price on Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 25th. Finally, TD Cowen reissued a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Eight research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $171.33.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.